BBS-Bioactive Bone Substitutes Oyj

<!-- Name:DistributionId Value:1000784602 --> <!-- Name:NewsArchiveTags Value:8877 --> <!-- Name:NewsArchiveOrgTags…

<!-- Name:DistributionId Value:1000783172 --> <!-- Name:NewsArchiveTags Value:8877 --> <!-- Name:NewsArchiveOrgTags…

<!-- Name:DistributionId Value:1000782299 --> <!-- Name:NewsArchiveTags Value:8877 --> <!-- Name:NewsArchiveOrgTags…

BBS-Bioactive Bone Substitutes, Company announcement, Insider information, 30 December 2022 at 2:00 p.m.  BBS updates estimate of the CE marking approval schedule of ARTEBONE® Paste   In March 2022, BBS-Bioactive Bone Substitutes Plc…

BBS-Bioactive Bone Substitutes Plc, Investor News, 22 December 2022 at 3.45 p.m. The management team of BBS-Bioactive Bone Substitutes Plc (BBS), including CEO Ilkka Kangasniemi, Chairman of the Board Jarmo Halonen, and Board…

BBS-Bioactive Bone Substitutes Oyj, Company Announcement, 9 December 2022 at 2.15 p.m. EET BBS-Bioactive Bone Substitutes: 69% of the warrants 1-2022 (WA1) used for the subscription of shares, company raises EUR 213 000 in gross…

BBS-Bioactive Bone Substitutes Oyj, Company release, 18 November 2022 at 2.30 p.m. EET BBS-Bioactive Bone Substitutes Oyj (BBS) organized a rights issue from May 18 to June 3, 2022. In connection with the share issue, a total…

BBS-Bioactive Bone Substitutes Oyj, Company release, Inside Information, 18 November 2022 at 2.30 p.m. EET The Notified Body has completed its first audit (15-18 November 2022) and has delivered its audit report to the company. The…